Literature DB >> 1237176

Neutralizing antibodies after rubella vaccination of newly delivered women: a comparison between three vaccines.

L Grillner.   

Abstract

Neutralizing (NT) antibody titres against rubella were determined in sera of 114 newly delivered women vaccinated with the Cendehill strain (Cendevax), the HPV-77 DE-5 strain (Meruvax) or the RA27/3 strain (Almevax). Blood samples were obtained before and 8 weeks as well as 2 years after the vaccination. Eight weeks after the vaccination NT antibodies were found in 56, 79 and 95% and after 2 years in 82, 94 and 100%, respectively. The differences between Cendevax and Almevax were statistically significant. Eight weeks postvaccination the median NT antibody titres were found to be 2, 4 and 4, respectively, while after 2 years the titres had further increased with one titration step. Levels of NT antibodies were observed to increase also after 8 weeks, i.e. during the period 8 weeks to 2 years postvaccination.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1237176     DOI： 10.3109/inf.1975.7.issue-3.03

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN： 0036-5548


  6 in total

1.  Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Jenna E Ryan; Neelam Dhiman; Robert A Vierkant; Gregory A Poland
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

2.  Comparison of the latex agglutination test with the hemagglutination inhibition test, enzyme-linked immunosorbent assay, and neutralization test for detection of antibodies to rubella virus.

Authors:  J M Meegan; B K Evans; D M Horstmann
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

3.  Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals.

Authors:  L A Mitchell; M K Ho; J E Rogers; A J Tingle; R G Marusyk; J M Weber; P Duclos; M L Tepper; M Lacroix; M Zrein
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

4.  Evaluation of the hemolysis-in-gel test for the screening of rubella immunity and the demonstration of recent infection.

Authors:  L Grillner; O Strannegård
Journal:  J Clin Microbiol       Date:  1976-02       Impact factor: 5.948

5.  Antibody titres in women six to eight years after the administration of RA2713 and Cendehill rubella vaccines.

Authors:  H Macdonald; J O Tobin; J E Cradock-Watson; J Lomax
Journal:  J Hyg (Lond)       Date:  1978-06

6.  Rubella in Orkney: seroepidemiology and vaccination.

Authors:  M A Moffat; S N Heywood; E Laughton; J J Gould; D S Freestone
Journal:  J Hyg (Lond)       Date:  1977-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.